| Title : In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects - Ignatowska-Jankowska_2014_Br.J.Pharmacol_171_1392 |
| Author(s) : Ignatowska-Jankowska BM , Ghosh S , Crowe MS , Kinsey SG , Niphakis MJ , Abdullah RA , Tao Q , ST ON , Walentiny DM , Wiley JL , Cravatt BF , Lichtman AH |
| Ref : British Journal of Pharmacology , 171 :1392 , 2014 |
| Abstract : Ignatowska-Jankowska_2014_Br.J.Pharmacol_171_1392 |
| ESTHER : Ignatowska-Jankowska_2014_Br.J.Pharmacol_171_1392 |
| PubMedSearch : Ignatowska-Jankowska_2014_Br.J.Pharmacol_171_1392 |
| PubMedID: 23848221 |
| Gene_locus related to this paper: human-MGLL |
| Gene_locus related to this paper: human-MGLL |
Ignatowska-Jankowska BM, Ghosh S, Crowe MS, Kinsey SG, Niphakis MJ, Abdullah RA, Tao Q, ST ON, Walentiny DM, Wiley JL, Cravatt BF, Lichtman AH (2014)
In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects
British Journal of Pharmacology
171 :1392
Ignatowska-Jankowska BM, Ghosh S, Crowe MS, Kinsey SG, Niphakis MJ, Abdullah RA, Tao Q, ST ON, Walentiny DM, Wiley JL, Cravatt BF, Lichtman AH (2014)
British Journal of Pharmacology
171 :1392